Neelam Shah
About Neelam Shah
Neelam Shah is the Manager of Global Regulatory Sciences at Bristol Myers Squibb in Mumbai, India, with extensive experience in regulatory affairs from her previous roles at Novartis.
Company
Neelam Shah is currently employed at Bristol Myers Squibb. She holds the position of Manager in Global Regulatory Sciences, India. Her responsibilities involve overseeing regulatory strategies and ensuring compliance with global standards from her base in Mumbai, Maharashtra, India.
Title
Neelam Shah serves as the Manager for Global Regulatory Sciences at Bristol Myers Squibb in Mumbai, Maharashtra. Her role includes managing regulatory submissions and developing strategies to meet global regulatory requirements.
Education and Expertise
Neelam Shah has an extensive educational background in pharmaceutical sciences and law. She obtained a Post Graduate Diploma in Regulatory Affairs from the Institute of Pharmaceutical Management, an L.L.B. from Jitendra Chauhan College Of Law, and a Post Graduate Diploma In Intellectual Property Rights from Government Law College, Mumbai. Additionally, she holds a Master of Pharmacy in Pharmaceutics and a Bachelor of Pharmacy from Bombay College of Pharmacy.
Previous Experience
Before joining Bristol Myers Squibb, Neelam Shah had an extensive career at Novartis. She served in several roles, including Senior Executive and Executive for Regulatory Affairs in Global Drug Development in India. She also briefly worked as a Regulatory Affairs Senior Executive in Novartis Indonesia. Her tenure at Novartis spanned from 2014 to 2021, where she developed her expertise in regulatory affairs.
Achievements
Neelam Shah has led the regulatory strategy for launching various pharmaceutical products in emerging markets. She played a key role in the regulatory approval for a new drug application, significantly reducing the time to market for a critical medication. She has developed training programs for new team members and contributed to the development of company-wide regulatory policies. Shah has also managed regulatory submissions for biosimilar products and collaborated with international regulatory agencies for smoother product registrations.